학술논문

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort
Document Type
Article
Source
In: Blood. (Blood, 2 June 2022, 139(22):3278-3289)
Subject
Language
English
ISSN
15280020
00064971